COFCO Biotechnology Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 11,996.578 million compared to CNY 9,306.025 million a year ago. Operating income was CNY 958.752 million compared to CNY 474.881 million a year ago. Net income was CNY 705.924 million compared to CNY 365.409 million a year ago. Basic earnings per share from continuing operations was CNY 0.3814 compared to CNY 0.1976 a year ago. Diluted earnings per share from continuing operations was CNY 0.3806 compared to CNY 0.1975 a year ago.